BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 23131123)

  • 21. MassARRAY spectrometry is more sensitive than PreTect HPV-Proofer and consensus PCR for type-specific detection of high-risk oncogenic human papillomavirus genotypes in cervical cancer.
    Basu P; Chandna P; Bamezai RN; Siddiqi M; Saranath D; Lear A; Ratnam S
    J Clin Microbiol; 2011 Oct; 49(10):3537-44. PubMed ID: 21813716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic performance of the E6/E7 mRNA-based Optimygene HR-HPV RT-qDx assay for cervical cancer screening.
    Wang HY; Kim H; Park KH
    Int J Infect Dis; 2019 Jan; 78():22-30. PubMed ID: 30248464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interest of cytology combined with Xpert
    Nassereddine H; Charpentier C; Bucau M; Joly V; Bienvenu L; Davitian C; Abramowitz L; Benabderrahmane D; Kotelevets L; Chastre E; Lehy T; Walker F
    HIV Med; 2018 Nov; 19(10):698-707. PubMed ID: 30062761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytology and human papillomavirus testing 6 to 12 months after ASCUS or LSIL cytology in organized screening to predict high-grade cervical neoplasia between screening rounds.
    Tropé A; Sjøborg KD; Nygård M; Røysland K; Campbell S; Alfsen GC; Jonassen CM
    J Clin Microbiol; 2012 Jun; 50(6):1927-35. PubMed ID: 22518869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection and genotyping of HPV in urine samples from Chilean women attending primary health care centers.
    Vergara N; Balanda M; Hidalgo W; Martín HS; Aceituno A; Roldán F; Villalón T; Hott M; Espinoza G; Quiero A; Valenzuela MT; Ramírez E
    Med Microbiol Immunol; 2018 Apr; 207(2):95-103. PubMed ID: 29238853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the Abbott RealTime High-Risk Human Papillomavirus (HPV), Roche Cobas HPV, and Hybrid Capture 2 assays to direct sequencing and genotyping of HPV DNA.
    Park Y; Lee E; Choi J; Jeong S; Kim HS
    J Clin Microbiol; 2012 Jul; 50(7):2359-65. PubMed ID: 22518863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of human papillomavirus infection in women undergoing routine cervical cancer screening in Spain: the CLEOPATRE study.
    Roura E; Iftner T; Vidart JA; Kjaer SK; Bosch FX; Muñoz N; Palacios S; Rodriguez MS; Morillo C; Serradell L; Torcel-Pagnon L; Cortes J; Castellsagué X;
    BMC Infect Dis; 2012 Jun; 12():145. PubMed ID: 22734435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human papillomavirus (HPV) is not the main cause of preinvasive and invasive cervical cancer among patients in Delta Region, Egypt.
    Thabet M; Hemida R; Hasan M; Elshamy M; Elfaraash M; Emam M
    J Exp Ther Oncol; 2014; 10(4):247-53. PubMed ID: 25509977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High performance of a new PCR-based urine assay for HPV-DNA detection and genotyping.
    Tanzi E; Bianchi S; Fasolo MM; Frati ER; Mazza F; Martinelli M; Colzani D; Beretta R; Zappa A; Orlando G
    J Med Virol; 2013 Jan; 85(1):91-8. PubMed ID: 23097252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the Anyplex II HPV28 assay with the Hybrid Capture 2 assay for the detection of HPV infection.
    Kwon MJ; Roh KH; Park H; Woo HY
    J Clin Virol; 2014 Apr; 59(4):246-9. PubMed ID: 24568964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative evaluation of AMPLICOR HPV PCR and Linear Array assays on SurePath liquid-based Pap samples for the detection of high-risk HPV genotypes.
    Chernesky M; Jang D; Portillo E; Smieja M; Chong S; Buracond S; Klingel M; El Sebai R; Kapala J; Patel J; Biers K; Harroun N; Doucette C; Sumner J
    J Clin Virol; 2011 Mar; 50(3):201-4. PubMed ID: 21195020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a liquid bead array system for high-risk human papillomavirus detection and genotyping in comparison with Hybrid Capture II, DNA chip and sequencing methods.
    Cho EJ; Do JH; Kim YS; Bae S; Ahn WS
    J Med Microbiol; 2011 Feb; 60(Pt 2):162-171. PubMed ID: 20965919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-risk HPV detection and genotyping by APTIMA HPV using cervical samples.
    Pyne MT; Hamula CL; Tardif K; Law C; Schlaberg R
    J Virol Methods; 2015 Sep; 221():95-9. PubMed ID: 25956671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of human papilloma virus testing in cervical cancer prevention.
    Fey MC; Beal MW
    J Midwifery Womens Health; 2004; 49(1):4-13. PubMed ID: 14710135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The evaluation of human papillomavirus genotyping in cervical liquid-based cytology specimens; using the Roche Linear Array HPV genotyping assay.
    Jamison J; Wilson RT; Carson J
    Cytopathology; 2009 Aug; 20(4):242-8. PubMed ID: 19291176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Human papillomavirus typing in routine cervical smears. Results from a series of 3778 patients].
    Levert M; Clavel C; Graesslin O; Masure M; Birembaut P; Quereux C; Gabriel R
    Gynecol Obstet Fertil; 2000 Oct; 28(10):722-8. PubMed ID: 11244634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cervical cancer screening by cytology and human papillomavirus testing during pregnancy in French women with poor adhesion to regular cervical screening.
    Brun-Micaleff E; Coffy A; Rey V; Didelot MN; Combecal J; Doutre S; Daurès JP; Segondy M; Boulle N
    J Med Virol; 2014 Mar; 86(3):536-45. PubMed ID: 24114972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of sexually transmitted infection and human papillomavirus in negative cytology by multiplex-PCR.
    Shim HS; Noh S; Park AR; Lee YN; Kim JK; Chung HJ; Kang KS; Cho NH
    BMC Infect Dis; 2010 Sep; 10():284. PubMed ID: 20920170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical performance of Invader technology and SurePath when detecting the presence of high-risk HPV cervical infection.
    Harvey M; Stout S; Starkey CR; Hendren R; Holt S; Miller GC
    J Clin Virol; 2009 Jul; 45 Suppl 1():S79-83. PubMed ID: 19651373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human papillomavirus prevalence in paired urine and cervical samples in women invited for cervical cancer screening.
    Burroni E; Bonanni P; Sani C; Lastrucci V; Carozzi F; ; Iossa A; Andersson KL; Brandigi L; Di Pierro C; Confortini M; Levi M; Boccalini S; Indiani L; Sala A; Tanini T; Bechini A; Azzari C
    J Med Virol; 2015 Mar; 87(3):508-15. PubMed ID: 25418873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.